VRDN - Viridian Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$38.13
DETAILS
HIGH:
$50.00
LOW:
$26.00
MEDIAN:
$36.50
CONSENSUS:
$38.13
UPSIDE:
121.17%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue | 70.8 | 0.3 | 0.3 | 1.8 | 3.0 | 1.1 | 4.5 | 8.4 | 4.0 | 3.3 | 2.5 | 4.3 | 4.3 | 4.4 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 28.3 | 0 | 30.4 | 19.6 | 2.5 | 2.5 | 3.2 | 2.5 | 3.0 |
| Gross Profit | 70.8 | 0.3 | 0.3 | 1.8 | 3.0 | (27.3) | 4.5 | (22.0) | (15.6) | 0.8 | 0.1 | 1.1 | 1.8 | 1.4 |
| Operating Expenses | ||||||||||||||
| R&D Expenses | 338.9 | 238.3 | 159.8 | 100.9 | 56.9 | 28.3 | 34.8 | 30.4 | 19.6 | 0.9 | 1.0 | 0.3 | 0.1 | 0.2 |
| SG&A Expenses | 95.3 | 61.1 | 95.0 | 35.2 | 25.8 | 13.3 | 11.6 | 11.0 | 10.9 | 9.6 | 10.3 | 7.8 | 2.2 | 4.2 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 41.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 434.2 | 299.3 | 254.8 | 136.1 | 82.7 | 83.1 | 46.4 | 41.5 | 30.5 | 10.5 | 11.3 | 8.0 | 2.3 | 4.5 |
| Operating Income | ||||||||||||||
| Operating Income | (363.4) | (299.0) | (254.4) | (134.3) | (79.7) | (110.4) | (42.0) | (33.1) | (26.5) | (12.5) | (11.2) | (6.9) | (0.2) | (4.0) |
| Interest Expense | 4.9 | 3.0 | 1.8 | 0.5 | 0.0 | 0.5 | 0.8 | 0.9 | 0.4 | 0.1 | 0.1 | 1.0 | 2.0 | 1.6 |
| Interest Income | 27.4 | 32.1 | 18.6 | 4.9 | 0.3 | 0.2 | 0.9 | 1.3 | 0.4 | 0 | 0 | 0 | 0 | 0 |
| Profitability | ||||||||||||||
| EBITDA | (337.2) | (265.7) | (235.4) | (129.1) | (79.3) | (40.3) | (40.8) | (31.5) | (25.8) | (12.5) | (11.0) | (6.7) | (0.0) | (3.9) |
| EBIT | (337.7) | (266.9) | (235.9) | (129.4) | (79.4) | (40.5) | (41.0) | (31.8) | (26.1) | (12.6) | (11.2) | (6.9) | (0.2) | (4.0) |
| Income Before Tax | (342.6) | (269.9) | (237.7) | (129.9) | (79.4) | (110.7) | (41.9) | (32.7) | (26.5) | (12.7) | (11.3) | (7.9) | (2.2) | (5.6) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0 | 0 | 2.0 | 0 |
| Net Income | (342.6) | (269.9) | (237.7) | (129.9) | (79.4) | (110.7) | (41.9) | (32.7) | (26.5) | (12.7) | (11.3) | (7.9) | (2.2) | (7.2) |
| Per Share Data | ||||||||||||||
| EPS (Basic) | -3.32 | -3.98 | -5.31 | -3.91 | -6.66 | -31.20 | -20.31 | -16.57 | -20.66 | -17.57 | -21.00 | -52.46 | -11.48 | -38.75 |
| EPS (Diluted) | -3.32 | -3.98 | -5.31 | -3.91 | -6.66 | -31.20 | -20.31 | -16.57 | -20.66 | -17.57 | -21.00 | -52.46 | -11.48 | -38.75 |
| Shares Outstanding | 84.8 | 67.9 | 44.8 | 32.1 | 11.9 | 3.6 | 2.1 | 2.0 | 1.3 | 0.7 | 0.5 | 0.2 | 0.2 | 0.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 212.4 | 99.6 | 102.8 | 155.6 | 42.3 | 45.9 | 24.8 | 32.6 | 47.4 | 3.3 |
| Short-Term Investments | 662.3 | 618.0 | 374.5 | 269.0 | 154.7 | 81.7 | 2.0 | 29.9 | 0 | 0 |
| Net Receivables | 0 | 0 | 0.1 | 0.1 | 0.5 | 0 | 0.1 | 0.0 | 1.5 | 0.5 |
| Inventory | 0 | 0 | 0 | (6.6) | 0 | 0 | 0 | 0 | 0 | 0.1 |
| Other Current Assets | 19.6 | 20.9 | 9.0 | 6.5 | 0 | 0 | (0.1) | 2.9 | 3.0 | 0.2 |
| Total Current Assets | 894.2 | 738.5 | 486.5 | 424.6 | 200.2 | 129.6 | 29.7 | 65.4 | 51.9 | 4.3 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 3.6 | 3.4 | 3.3 | 2.9 | 2.1 | 0.8 | 0.5 | 0.7 | 0.6 | 0.6 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.5 | 0.5 | 0.6 | 7.6 | 1.5 | 0.9 | 0 | 0.1 | 0.1 | 0.3 |
| Total Non-Current Assets | 5.2 | 3.9 | 3.9 | 10.5 | 3.5 | 1.6 | 0.5 | 0.8 | 0.6 | 0.9 |
| Total Assets | 899.4 | 742.4 | 490.4 | 435.1 | 203.7 | 131.3 | 30.3 | 66.1 | 52.5 | 4.3 |
| Current Liabilities | ||||||||||
| Account Payables | 8.7 | 2.1 | 2.2 | 14.2 | 2.3 | 0.7 | 1.1 | 0.6 | 0.9 | 0.2 |
| Short-Term Debt | 0.8 | 0 | 0 | 0 | 0 | 0 | 4.0 | 2.3 | 0 | 0 |
| Deferred Revenue | 0 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0 | 3.8 | 0 | 3.4 |
| Other Current Liabilities | 61.3 | 10.7 | 12.8 | 4.9 | 3.8 | 7.3 | 0.7 | 0.2 | 0.4 | 1.2 |
| Total Current Liabilities | 70.7 | 47.9 | 26.6 | 33.3 | 13.6 | 10.7 | 10.2 | 6.7 | 3.9 | 4.6 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 49.9 | 20.6 | 20.2 | 4.6 | 0 | 0 | 4.3 | 8.0 | 9.9 | 2.8 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 56.6 | 2.0 | 1.0 | 1.2 | 1.2 | 0.5 | 0 | 0.1 | 0.2 | 0 |
| Total Non-Current Liabilities | 106.6 | 22.9 | 21.8 | 6.7 | 2.4 | 0.5 | 4.3 | 8.1 | 10.1 | 2.8 |
| Total Liabilities | 177.3 | 70.8 | 48.4 | 40.0 | 16.0 | 11.2 | 14.5 | 14.8 | 14.0 | 4.6 |
| Stockholders' Equity | ||||||||||
| Common Stock | 1.0 | 0.8 | 0.5 | 0.4 | 0.2 | 0.0 | 0.0 | 0.3 | 0.2 | 0.0 |
| Retained Earnings | (1,338.5) | (995.9) | (725.9) | (488.2) | (358.3) | (278.9) | (168.2) | (126.3) | (93.6) | (30.6) |
| Accumulated Other Comprehensive Income | 0.4 | (0.0) | 0.3 | (0.4) | (0.2) | (0.0) | 0 | (0.0) | (2.8) | 0 |
| Total Stockholders' Equity | 722.2 | 671.6 | 442.0 | 395.1 | 187.7 | 120.0 | 15.8 | 51.3 | 38.5 | (0.3) |
| Total Liabilities & Equity | 899.4 | 742.4 | 490.4 | 435.1 | 203.7 | 131.3 | 30.3 | 66.1 | 52.5 | 4.3 |
| Debt Metrics | ||||||||||
| Total Debt | 50.7 | 21.1 | 21.0 | 5.3 | 0.5 | 0.5 | 8.3 | 10.3 | 9.9 | 1.0 |
| Net Debt | (161.7) | (78.5) | (81.8) | (150.3) | (41.8) | (45.4) | (16.5) | (22.3) | (37.5) | (2.3) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (342.6) | (269.9) | (237.7) | (129.9) | (79.4) | (110.7) | (41.9) | (32.7) | (26.5) | (12.7) |
| Depreciation & Amortization | (6.8) | 0.5 | 0.5 | 0.3 | 0.1 | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 |
| Stock-Based Compensation | 44.3 | 42.1 | 67.2 | 19.8 | 14.5 | 3.6 | 4.0 | 3.7 | 2.4 | 2.1 |
| Change in Working Capital | 23.0 | 9.6 | (9.4) | 16.0 | 1.7 | 4.4 | 1.7 | 1.9 | (4.5) | 2.2 |
| Other Non-Cash Items | 5.6 | (14.7) | (4.7) | 0.1 | 8.5 | 72.6 | 0.3 | 0.4 | 0.1 | 0.1 |
| Operating Cash Flow | (276.4) | (232.3) | (184.2) | (93.8) | (54.6) | (29.8) | (36.1) | (26.8) | (28.2) | (7.2) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.5) | (0.5) | (0.9) | (0.8) | (0.3) | (0.0) | (0.1) | (0.4) | (0.2) | (0.0) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 29.4 | (28.3) | 0 | 1.3 | 0 |
| Purchases of Investments | (579.3) | (695.1) | (407.9) | (223.3) | (188.4) | (81.8) | (32.7) | (62.5) | 0 | (1) |
| Sales/Maturities of Investments | 542.2 | 466.9 | 314.5 | 108.9 | 114.4 | 2 | 61 | 33 | 0 | 1 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0.1 | (0.0) | 28.3 | (29.5) | 1.3 | 0 |
| Investing Cash Flow | (37.6) | (228.7) | (94.3) | (115.1) | (74.3) | (50.5) | 28.2 | (29.9) | 1.0 | (0.0) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 28.9 | 0 | 15 | 5 | 0 | (8.6) | (2.3) | 0 | 5.3 | (0.3) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.2) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 49.5 | (20.9) | 9.4 | (18.6) | (5.9) | (6.2) | 0 | (2.6) | (1.4) | 0.1 |
| Financing Cash Flow | 426.7 | 457.7 | 225.7 | 322.2 | 125.3 | 101.3 | 0.1 | 41.9 | 52.5 | (0.3) |
| Cash Position | ||||||||||
| Net Change in Cash | 112.8 | (3.2) | (52.8) | 113.3 | (3.6) | 21.1 | (7.8) | (14.8) | 25.3 | (7.5) |
| Cash at Beginning | 99.6 | 102.8 | 155.6 | 42.3 | 45.9 | 24.8 | 32.6 | 47.4 | 22.1 | 10.8 |
| Cash at End | 212.4 | 99.6 | 102.8 | 155.6 | 42.3 | 45.9 | 24.8 | 32.6 | 47.4 | 3.3 |
| Free Cash Flow | (276.9) | (232.8) | (185.1) | (94.6) | (54.9) | (29.8) | (36.1) | (27.3) | (28.4) | (7.2) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | 70.8 | 0.3 | 0.3 | 1.8 | 3.0 | 1.1 | 4.5 | 8.4 | 4.0 | 3.3 | 2.5 | 4.3 | 4.3 | 4.4 |
| Gross Profit | 70.8 | 0.3 | 0.3 | 1.8 | 3.0 | (27.3) | 4.5 | (22.0) | (15.6) | 0.8 | 0.1 | 1.1 | 1.8 | 1.4 |
| Operating Income | (363.4) | (299.0) | (254.4) | (134.3) | (79.7) | (110.4) | (42.0) | (33.1) | (26.5) | (12.5) | (11.2) | (6.9) | (0.2) | (4.0) |
| Net Income | (342.6) | (269.9) | (237.7) | (129.9) | (79.4) | (110.7) | (41.9) | (32.7) | (26.5) | (12.7) | (11.3) | (7.9) | (2.2) | (7.2) |
| EPS (Diluted) | -3.32 | -3.98 | -5.31 | -3.91 | -6.66 | -31.20 | -20.31 | -16.57 | -20.66 | -17.57 | -21.00 | -52.46 | -11.48 | -38.75 |
| Balance Sheet | ||||||||||||||
| Cash & Equivalents | 212.4 | 99.6 | 102.8 | 155.6 | 42.3 | 45.9 | 24.8 | 32.6 | 47.4 | 3.3 | ||||
| Total Assets | 899.4 | 742.4 | 490.4 | 435.1 | 203.7 | 131.3 | 30.3 | 66.1 | 52.5 | 4.3 | ||||
| Total Debt | 50.7 | 21.1 | 21.0 | 5.3 | 0.5 | 0.5 | 8.3 | 10.3 | 9.9 | 1.0 | ||||
| Stockholders' Equity | 722.2 | 671.6 | 442.0 | 395.1 | 187.7 | 120.0 | 15.8 | 51.3 | 38.5 | (0.3) | ||||
| Cash Flow | ||||||||||||||
| Operating Cash Flow | (276.4) | (232.3) | (184.2) | (93.8) | (54.6) | (29.8) | (36.1) | (26.8) | (28.2) | (7.2) | ||||
| Capital Expenditure | (0.5) | (0.5) | (0.9) | (0.8) | (0.3) | (0.0) | (0.1) | (0.4) | (0.2) | (0.0) | ||||
| Free Cash Flow | (276.9) | (232.8) | (185.1) | (94.6) | (54.9) | (29.8) | (36.1) | (27.3) | (28.4) | (7.2) | ||||